LOIBNER HANS has a total of 17 patent applications. Its first patent ever was published in 2001. It filed its patents most often in United States, Argentina and Australia. Its main competitors in its focus markets pharmaceuticals, measurement and biotechnology are KADOWAKI TAKASHI, HUDSON INSTITUTE OF MEDICAL RES and PROTEOSYS AG.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 9 | |
#2 | Argentina | 2 | |
#3 | Australia | 2 | |
#4 | Canada | 1 | |
#5 | EPO (European Patent Office) | 1 | |
#6 | Peru | 1 | |
#7 | Taiwan | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Measurement | |
#3 | Biotechnology | |
#4 | Agriculture |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Analysing materials | |
#3 | Medical preparations | |
#4 | Peptides | |
#5 | Microorganisms | |
#6 | Animal care | |
#7 | Measuring microorganism processes |
# | Name | Total Patents |
---|---|---|
#1 | Loibner Hans | 15 |
#2 | Schuster Manfred | 6 |
#3 | Janzek-Hawlat Evelyne | 2 |
#4 | Eckert Helmut | 2 |
#5 | Lode Holger | 1 |
#6 | Mutschlechner Oliver | 1 |
#7 | Peball Bernhard | 1 |
#8 | Lametschwandtner Gunther | 1 |
#9 | Wolf Dominik | 1 |
#10 | Groiss Franz | 1 |
Publication | Filing date | Title |
---|---|---|
AU2007304869A1 | General prognostic parameters for tumour patients | |
TW200826902A | Predictive parameters | |
US2006018901A1 | Use of antibodies in a very low dose for the vaccination against cancer | |
US6956119B2 | Polysaccharide-polypeptide conjugate |